Stopping prophylactic treatment in patients with rheumatic disease on > 12.5 mg/d of prednisone-equivalent corticosteroids ...

Immunocompromised patients with severe community-acquired pneumonia have an increased risk of in-hospital and long-term mortality.

Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) - a ...